Stem cell research is one of the main focuses of the University of Basel. In the Basel Stem Cell Network (BSCN) center of excellence, basic researchers, pharmaceutical researchers, medical professionals, lawyers, and ethicists work together to answer questions in this fascinating field of research, considered by many to be regenerative medicine and the therapy of the 21st century. Research groups from the Biozentrum, the Department of Biomedicine, the Basel University Hospital, the Friedrich Miescher Institute (FMI), as well as the Department of Biosystems Science and Engineering (D-BSSE) of the Swiss Federal Institute of Technology (ETH) Zurich, and the Novartis and Roche pharmaceutical companies, are all involved in the BSCN.